Monsanto Company (MON) Releases Earnings Results, Misses Expectations By $-0.23 EPS

Monsanto Company (MON) reported quarterly earnings results on Wednesday, Jun-29-2016. The company reported $2.17 earnings per share for the quarter, missing the analyst consensus estimate by $-0.23. Analysts had a consensus of $2.40. The company posted revenue of $4189.00 million in the period, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016. Shares were Reiterated by Deutsche Bank on Apr 7, 2016 to “Buy” and Lowered the Price Target to $ 100 from a previous price target of $105 .

Monsanto Company closed down -4.09 points or -3.93% at $99.98 with 64,33,138 shares getting traded on Monday. Post opening the session at $102.86, the shares hit an intraday low of $98.92 and an intraday high of $103.77 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

Investors should note that on Jun 9, 2016, Monsanto Company announced a cash dividend of $0.5400. The company’s management has announced Jul 6, 2016 as the ex-dividend date and fixed the record date on Jul 8, 2016. The payable date has been fixed on Jul 29, 2016.

In a different news, on Apr 21, 2016, George Poste (director) sold 1,136 shares at $91.93 per share price. According to the SEC, on Apr 18, 2016, Steven Mizell (EVP, Chief HR Officer) sold 9,500 shares at $89.06 per share price. On Apr 18, 2016, Charles S Mcmillan (director) purchased 3,500 shares at $87.25 per share price, according to the Form-4 filing with the securities and exchange commission.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Monsanto Company

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.